Cancer

2 weeks ago | acsjournals.onlinelibrary.wiley.com | Bryn Nelson |William C. Faquin

Despite the inroads made in improving treatments for a wide range of cancers, researchers are coming to grips with the unsettling realization that malignant cells still have a surprising number of escape routes. Block one, and another seems to open up.

2 weeks ago | acsjournals.onlinelibrary.wiley.com | Monica Chen |Michael A. Postow

Please review our Terms and Conditions of Use and check box below to share full-text version of article. I have read and accept the Wiley Online Library Terms and Conditions of UseUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.

3 weeks ago | acsjournals.onlinelibrary.wiley.com | Brigid Lynch |Julie Bassett |Roger Milne |Alpa Patel

Corresponding Author Brigid M. Lynch PhD Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia Physical Activity Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia Correspondence Brigid M. Lynch, Cancer Epidemiology Division, Cancer Council Victoria, Level 8, 200 Victoria Parade East, Melbourne 3002, Victoria, Australia.

3 weeks ago | acsjournals.onlinelibrary.wiley.com | Jasmine A Ebott |Kelsea R. Grant |John Farley |Marina Stasenko

CONFLICT OF INTEREST STATEMENT Marina Stasenko received compensation for participation on Healthcare Disparities in Endometrial Cancer Advisory Board in July 2024, sponsored by GSK. The other authros declare no conflicts of interest. REFERENCES 1, , , , , . The gender authorship gap in gynecologic oncology research. Gynecol Oncol Rep. 2019; 29: 83-84. doi:10.1016/j.gore.2019.07.011 2, , , et al. Take me to your leader: reporting structures and equity in academic gynecologic oncology.

1 month ago | acsjournals.onlinelibrary.wiley.com | Judy A. Trieu |Andrew Gilman |Katerina Konstantinoff |Maria Lozano

INTRODUCTION Pancreatic lesions are rising in prevalence, likely because of increasing access to cross-sectional imaging. They can be subtyped into neoplastic and non-neoplastic lesions. Some lesions are characteristic on computed tomography (CT), magnetic resonance imaging (MRI), and/or endoscopic ultrasound (EUS), whereas others are nonspecific.